{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:53:26Z","timestamp":1783666406445,"version":"3.55.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.joms.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T23:53:25Z","timestamp":1466034805000},"page":"105-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Adjuvant Antiangiogenic Treatment for Aggressive Giant Cell Lesions of the Jaw: A 20-Year Experience at Massachusetts General Hospital"],"prefix":"10.1016","volume":"75","author":[{"given":"Willem H.","family":"Schreuder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S.","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Kiang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Kaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2016.06.007_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcms.2010.11.010","article-title":"Treatment of central giant-cell granulomas of the jaws in children: Conservative or radical surgical approach?","volume":"39","author":"Theologie-Lygidakis","year":"2011","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0030-4220(59)90215-4","article-title":"Giant-cell reparative granuloma and related conditions affecting the jawbones","volume":"12","author":"Austin","year":"1959","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.joms.2016.06.007_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.tripleo.2007.04.003","article-title":"Central giant cell granuloma of the jaw: A review of the literature with emphasis on therapy options","volume":"104","author":"de Lange","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2016.06.007_bib4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0278-2391(86)90040-6","article-title":"Central giant cell lesions of the jaws: A clinicopathologic study","volume":"44","author":"Chuong","year":"1986","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0030-4220(87)90115-0","article-title":"Central giant cell lesions of the mandible and maxilla: A clinicopathologic and cytometric study","volume":"64","author":"Ficarra","year":"1987","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.joms.2016.06.007_bib6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/joms.2002.33241","article-title":"The surgical treatment of central giant cell granuloma of the mandible","volume":"60","author":"Bataineh","year":"2002","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1042-3699(20)30771-8","article-title":"Management of central giant cell lesions. An alternative to surgical therapy","volume":"6","author":"Terry","year":"1994","journal-title":"Oral Maxillofacial Surg Clin N Am"},{"key":"10.1016\/j.joms.2016.06.007_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0266-4356(93)90168-V","article-title":"Central giant cell granulomas of the jaws regress with calcitonin therapy","volume":"31","author":"Harris","year":"1993","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0278-2391(99)90828-5","article-title":"Calcitonin treatment for central giant cell granulomas of the mandible: Report of two cases","volume":"57","author":"Pogrel","year":"1999","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib10","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1542\/peds.103.6.1145","article-title":"Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a","volume":"103","author":"Kaban","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.joms.2016.06.007_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00973194","article-title":"Intraarterial management of giant-cell tumors of the spine in children","volume":"12","author":"Eftekhari","year":"1982","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.joms.2016.06.007_bib12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1053\/joms.2002.34975","article-title":"Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws","volume":"60","author":"Kaban","year":"2002","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib13","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.joms.2007.03.030","article-title":"Adjuvant antiangiogenic therapy for giant cell tumors of the jaws","volume":"65","author":"Kaban","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.6154315","article-title":"Inhibition of cell motility by interferon","volume":"208","author":"Brouty-Boye","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.joms.2016.06.007_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jnci\/81.7.497","article-title":"Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice","volume":"81","author":"Dvorak","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.joms.2016.06.007_bib16","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJM198905043201811","article-title":"Successful treatment of an angiogenic disease","volume":"320","author":"Folkman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2016.06.007_bib17","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJM199512283332608","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis","volume":"333","author":"Folkman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2016.06.007_bib18","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0022-3468(05)80327-6","article-title":"Successful management of an infant with a giant hemangioma of the retroperitoneum and Kasabach-Merritt syndrome with alpha-interferon","volume":"28","author":"Hatley","year":"1993","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archopht.1992.01080220028008","article-title":"Treatment of a massive orbital-capillary hemangioma with interferon alfa-2b: Short-term results","volume":"110","author":"Loughnan","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.joms.2016.06.007_bib20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archotol.1995.01890060088018","article-title":"The use of interferon alfa-2a for life-threatening hemangiomas","volume":"121","author":"MacArthur","year":"1995","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000348949410300101","article-title":"Interferon alfa-2a therapy for airway hemangiomas","volume":"103","author":"Ohlms","year":"1994","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.joms.2016.06.007_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(89)90694-6","article-title":"Treatment of\u00a0haemangioendotheliomas with alpha interferon","volume":"2","author":"Orchard","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.joms.2016.06.007_bib23","first-page":"5155","article-title":"Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses","volume":"47","author":"Sidky","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.joms.2016.06.007_bib24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/jir.1987.7.619","article-title":"Does successful interferon treatment of tumor patients require life-long treatment?","volume":"7","author":"Strander","year":"1987","journal-title":"J Interferon Res"},{"key":"10.1016\/j.joms.2016.06.007_bib25","doi-asserted-by":"crossref","first-page":"E1418","DOI":"10.1097\/BRS.0b013e3181e7bf5a","article-title":"Interferon alfa-2b for recurrent and metastatic giant cell tumor of the spine: Report of two cases","volume":"35","author":"Wei","year":"2010","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.joms.2016.06.007_bib26","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1056\/NEJM198905043201807","article-title":"Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a","volume":"320","author":"White","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2016.06.007_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-3476(05)81844-X","article-title":"Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a","volume":"118","author":"White","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.joms.2016.06.007_bib28","first-page":"415","article-title":"Interferon therapy for vascular tumors of bone","volume":"13","author":"Yasko","year":"2001","journal-title":"Curr Opin Orthop"},{"key":"10.1016\/j.joms.2016.06.007_bib29","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ijom.2010.06.015","article-title":"Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant-cell granuloma in 21 cases","volume":"39","author":"Nogueira","year":"2010","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","article-title":"Interferons and their actions","volume":"56","author":"Pestka","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.joms.2016.06.007_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.joms.2016.06.007_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00001622-200311000-00005","article-title":"Interferons: Mechanisms of action and clinical applications","volume":"15","author":"Parmar","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.joms.2016.06.007_bib33","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays","volume":"95","author":"Der","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.joms.2016.06.007_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1525-1470.1993.tb00020.x","article-title":"Supraumbilical midabdominal raphe, sternal atresia, and hemangioma in an infant: Response of hemangioma to laser and interferon alfa-2a","volume":"10","author":"Blei","year":"1993","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.joms.2016.06.007_bib35","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199205283262203","article-title":"Interferon alfa-2a therapy for life-threatening hemangiomas of infancy","volume":"326","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2016.06.007_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00000658-199406000-00003","article-title":"Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood","volume":"219","author":"Ricketts","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib37","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.joms.2009.06.042","article-title":"Aggressive central giant cell granuloma of the mandible","volume":"68","author":"Schutz","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11845-012-0858-x","article-title":"Aggressive giant cell granuloma of the jaws treated with interferon alpha: A report of two cases","volume":"182","author":"O\u2019Connell","year":"2013","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.joms.2016.06.007_bib39","first-page":"170","article-title":"Experience with anti-angiogenic therapy of giant cell granuloma of the facial bones","volume":"15","author":"Collins","year":"2000","journal-title":"Ann R Australas Coll Dent Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ijom.2006.02.011","article-title":"Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: A report of 2 cases","volume":"35","author":"de Lange","year":"2006","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib41","first-page":"3354","article-title":"Efficient inhibition of in\u00a0vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development","volume":"6","author":"Hong","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2016.06.007_bib42","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archderm.1997.03890480087013","article-title":"Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas","volume":"133","author":"Tamayo","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.joms.2016.06.007_bib43","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1542\/peds.103.6.1282","article-title":"Interferon and giant cell tumors","volume":"103","author":"Dickerman","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.joms.2016.06.007_bib44","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.joms.2006.04.006","article-title":"Effect of interferon-alpha-2b on porcine mesenchymal stem cells","volume":"64","author":"Abukawa","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tripleo.2004.11.024","article-title":"Complications of alpha-interferon therapy for aggressive central giant cell lesion of the maxilla","volume":"100","author":"Goldman","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.joms.2016.06.007_bib46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00001813-199212000-00002","article-title":"Neurotoxicity of interferon-alpha","volume":"3","author":"Merimsky","year":"1992","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.joms.2016.06.007_bib47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1375::AID-CNCR22>3.0.CO;2-D","article-title":"The effect of interferon on mouse myocardial capillaries: An ultrastructural study","volume":"85","author":"Salman","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2016.06.007_bib48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0022-3476(98)70034-4","article-title":"Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy","volume":"132","author":"Barlow","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.joms.2016.06.007_bib49","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1359\/jbmr.2002.17.10.1859","article-title":"Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in\u00a0vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in\u00a0vitro","volume":"17","author":"Collin-Osdoby","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2016.06.007_bib50","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1073\/pnas.92.10.4562","article-title":"Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas","volume":"92","author":"Singh","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.joms.2016.06.007_bib51","first-page":"2726","article-title":"Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule","volume":"5","author":"Slaton","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2016.06.007_bib52","first-page":"808","article-title":"Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration","volume":"58","author":"Dinney","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.joms.2016.06.007_bib53","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jnci\/95.6.437","article-title":"Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis","volume":"95","author":"von Marschall","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.joms.2016.06.007_bib54","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.bcp.2009.01.007","article-title":"Mechanisms of interferon-beta effects on bone homeostasis","volume":"77","author":"Abraham","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.joms.2016.06.007_bib55","first-page":"469","article-title":"Interferon-alpha inhibits in\u00a0vitro osteoclast differentiation and renal cell carcinoma-induced angiogenesis","volume":"30","author":"Avnet","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.joms.2016.06.007_bib56","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta","volume":"416","author":"Takayanagi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.joms.2016.06.007_bib57","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1186\/ar581","article-title":"Signaling crosstalk between RANKL and interferons in osteoclast differentiation","volume":"4(Suppl 3)","author":"Takayanagi","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.joms.2016.06.007_bib58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.0105-2896.2005.00337.x","article-title":"Interplay between interferon and other cytokine systems in bone metabolism","volume":"208","author":"Takayanagi","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.joms.2016.06.007_bib59","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0024-3205(03)00434-X","article-title":"Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions","volume":"73","author":"Kumta","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.joms.2016.06.007_bib60","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/hupa.2000.8441","article-title":"Gene expression of vascular endothelial growth factor in giant cell tumors of bone","volume":"31","author":"Zheng","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.joms.2016.06.007_bib61","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<372::AID-JCB6>3.0.CO;2-H","article-title":"Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in\u00a0vitro","volume":"74","author":"Oreffo","year":"1999","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.joms.2016.06.007_bib62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S8756-3282(98)00094-5","article-title":"Lymphoblastoid interferon-alpha downregulates parathyroid hormone (PTH)\/PTH-related peptide (PTHrP) receptor expression in human osteoblastic cells (Saos-2)","volume":"23","author":"Tsuda-Futami","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.joms.2016.06.007_bib63","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1432-1033.1990.tb19377.x","article-title":"Interferons and bone. A comparison of the effects of interferon-alpha and interferon-gamma in cultures of human bone-derived cells and an osteosarcoma cell line","volume":"193","author":"Beresford","year":"1990","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.joms.2016.06.007_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF01212729","article-title":"Generalised giant-cell tumour of bone: Successful treatment of pulmonary metastases with interferon alpha, a case report","volume":"119","author":"Kaiser","year":"1993","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.joms.2016.06.007_bib65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0030-4220(88)90094-1","article-title":"A clinical and histomorphologic comparison of the central giant cell granuloma and the giant cell tumor","volume":"66","author":"Auclair","year":"1988","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.joms.2016.06.007_bib66","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.joms.2011.12.005","article-title":"Do histologic criteria predict biologic behavior of giant cell lesions?","volume":"70","author":"Peacock","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2016.06.007_bib67","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.joms.2009.04.106","article-title":"Maxillofacial and axial\/appendicular giant cell lesions: Unique tumors or variants of the same disease?\u2014A comparison of phenotypic, clinical, and radiographic characteristics","volume":"68","author":"Resnick","year":"2010","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239116302531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239116302531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:50:27Z","timestamp":1759510227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239116302531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0278239116302531"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2016.06.007","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant Antiangiogenic Treatment for Aggressive Giant Cell Lesions of the Jaw: A 20-Year Experience at Massachusetts General Hospital","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}